Correspondence Clinical Letter erythrocytes. These channels were lined by neoplastic cells Clinical Letter that were negative for endothelial markers D2-40 and CD- 31. Further immunohistochemical staining showed consis- tent positivity for melanocytic markers (S-100, SOX-9, and HMB-45) and negativity for cytokeratins A1–A3 (Figure 2). Given the clinical and histological findings, a diagnosis DOI: 10.1111/ddg.13437 of primary angiomatoid melanoma (Clark level III, Bres- low thickness 5.2 mm, with evidence of ulceration between Dear Editors, 3–5 mm) was established. Whole-body positron emission to- mography-computed tomography (PET-CT) was performed, A 63-year-old woman with no relevant medical history revealing metastatic disease in the lungs, liver, and celiac presented to our hospital with changes in the morphology lymph nodes. Genetic testing for both V600E and V600K and color of a chronic cutaneous lesion. Two weeks prior mutations of the BRAF gene was performed using real-time to consultation, the lesion had bled profusely, subsequently PCR (THxID-BRAF AMP, bioMérieux, France), revealing decreasing significantly in size. Dermatological examination a V600E mutation. Following the diagnosis, the patient was revealed a purplish tumor (1.5 cm in diameter) in the right referred to the oncology department and started on vemura- scapular region, arising from a slightly raised brown papule. fenib
Journal Der Deutschen Dermatologischen Gesellschaft – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera